Dopamine-endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30297767.
- Also identified by DOI 10.1038/s41467-018-06409-5 and PMC identifier 6175920.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Dopamine modulates striatal synaptic plasticity, a key substrate for action selection and procedural learning. Thus, characterizing the repertoire of activity-dependent plasticity in striatum and its dependence on dopamine is of crucial importance. We recently unraveled a striatal spike-timing-dependent long-term potentiation (tLTP) mediated by endocannabinoids (eCBs) and induced with few spikes (~5-15). Whether this eCB-tLTP interacts with the dopaminergic system remains to be investigated. Here, we report that eCB-tLTP is impaired in a rodent model of Parkinson's disease and rescued by L-DOPA. Dopamine controls eCB-tLTP via dopamine type-2 receptors (D<sub>2</sub>R) located presynaptically in cortical terminals. Dopamine-endocannabinoid interactions via D<sub>2</sub>R are required for the emergence of tLTP in response to few coincident pre- and post-synaptic spikes and control eCB-plasticity by modulating the long-term potentiation (LTP)/depression (LTD) thresholds. While usually considered as a depressing synaptic function, our results show that eCBs in the presence of dopamine constitute a versatile system underlying bidirectional plasticity implicated in basal ganglia pathophysiology.
Medical subject headings
- Dopamine
- Endocannabinoids
- Long-Term Potentiation
- Neostriatum